Immunosuppression via tryptophan catabolism: The role of kynurenine pathway enzymes

被引:81
|
作者
Belladonna, Maria Laura
Puccetti, Paolo
Orabona, Ciriana
Fallarino, Francesca
Vacca, Carmine
Volpi, Claudia
Gizzi, Stefania
Pallotta, Maria Teresa
Fioretti, Maria Cristina
Grohmann, Ursula
机构
[1] Univ Perugia, Dept Expt Med, Pharmacol Sect, I-06126 Perugia, Italy
[2] Univ Perugia, Dept Expt Med & Biochem Sci, I-06100 Perugia, Italy
[3] Univ Perugia, Dept Clin & Expt Med, I-06100 Perugia, Italy
关键词
dendritic cells; indoleamine 2,3-dioxygenase; tolerance;
D O I
10.1097/01.tp.0000269199.16209.22
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Tryptophan catabolism occurring in dendritic cells (DCs) and initiated by indoleamine 2,3-dioxygenase (IDO) is an emerging major mechanism of peripheral tolerance. Here we provide evidence that: 1) tryptophan conversion to kynurenines is activated in DCs by cytotoxic T lymphocyte antigen 4, both in a soluble form or anchored to the regulatory T cell (T-reg) membrane; 2) an increased IDO-dependent tolerogenesis correlates with the inhibition of DAP12 functions, an adapter molecule associated with activating receptors; 3) a tolerogenic phenotype can be acquired by DCs lacking functional IDO through the paracrine production of kynurenines by IDO-competent DCs; 4) the suppressive effect of T-reg generated in a microenvironment with low tryptophan concentration and a mixture of kynurenines can protect mice in an experimental model of fulminant diabetes. Altogether, these data indicate that, in addition to tryptophan starvation induced by IDO activity, the paracrine production of kynurenines by enzymes downstream of IDO can also contribute to tolerogenesis in DCs, independently of tryptophan deprivation.
引用
收藏
页码:S17 / S20
页数:4
相关论文
共 50 条
  • [41] The role of placental tryptophan catabolism
    Sedlmayr, Peter
    Blaschitz, Astrid
    Stocker, Roland
    FRONTIERS IN IMMUNOLOGY, 2014, 5
  • [42] The role of placental tryptophan catabolism
    Sedlmayr, P.
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2013, 70 : 12 - 12
  • [43] Chemistry and neurochemistry of the kynurenine pathway of tryptophan metabolism
    Botting, NP
    CHEMICAL SOCIETY REVIEWS, 1995, 24 (06) : 401 - &
  • [44] BLOCKED KYNURENINE PATHWAY OF TRYPTOPHAN METABOLISM IN HEPATOMA
    CLAUDATUS, J
    GINORI, S
    SCIENCE, 1957, 125 (3244) : 394 - 395
  • [45] Tryptophan Catabolism to Serotonin and Kynurenine in Women Undergoing in-vitro Fertilization
    Bodis, Jozsef
    Sulyok, Endre
    Koppan, Miklos
    Varnagy, Akos
    Premusz, Viktoria
    Godony, Krisztina
    Rascher, Wolfgang
    Rauh, Manfred
    PHYSIOLOGICAL RESEARCH, 2020, 69 (06) : 1113 - 1124
  • [46] Kynurenine pathway enzymes in guinea pigs
    Allegri, G
    Costa, CVL
    Ragazzi, E
    Bertazzo, A
    Biasiolo, M
    DEVELOPMENTS IN TRYPTOPHAN AND SEROTONIN METABOLISM, 2003, 527 : 465 - 471
  • [47] TRYPTOPHAN-METABOLISM VIA THE KYNURENINE PATHWAY IN PATIENTS WITH THE EOSINOPHILIA-MYALGIA-SYNDROME
    SILVER, RM
    MCKINLEY, K
    SMITH, EA
    QUEARRY, B
    HARATI, Y
    STERNBERG, EM
    HEYES, MP
    ARTHRITIS AND RHEUMATISM, 1992, 35 (09): : 1097 - 1105
  • [48] Tryptophan Metabolism via the Kynurenine Pathway: Implications for Graft Optimization during Machine Perfusion
    Zhang, Anna
    Carroll, Cailah
    Raigani, Siavash
    Karimian, Negin
    Huang, Viola
    Nagpal, Sonal
    Beijert, Irene
    Porte, Robert J.
    Yarmush, Martin
    Uygun, Korkut
    Yeh, Heidi
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (06) : 1 - 14
  • [49] Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?
    Mellor, AL
    Munn, DH
    IMMUNOLOGY TODAY, 1999, 20 (10): : 469 - 473
  • [50] Reversal of the Kynurenine Pathway of Tryptophan Catabolism May Improve Depression in ART-Treated HIV-Infected Ugandans
    Martinez, Priscilla
    Tsai, Alexander C.
    Muzoora, Conrad
    Kembabazi, Annet
    Weiser, Sheri D.
    Huang, Yong
    Haberer, Jessica E.
    Martin, Jeffrey N.
    Bangsberg, David R.
    Hunt, Peter W.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2014, 65 (04) : 456 - 462